MedTrace Logo

Epidemiology Study on Insulin-like Growth Factor-1 in Children With Idiopathic Short Stature (EPIGROW Study)

NCT00710307 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 275

Last updated 2019-01-15

No results posted yet for this study

Summary

The purpose of the protocol is to describe the distribution of IGF-1 deficiency in the studied population of Idiopathic Short Children without Growth Hormone Deficiency or any other identified cause of short stature and not treated with recombinant Growth Hormone or IGF-1

Conditions

  • Idiopathic Short Stature

Interventions

PROCEDURE

Blood sampling

Blood samples will be collected at visit 1 (day 1) and at visit 2 (day 14 to 45).

GENETIC

Genetic analysis

The sample for genetic analyses may be taken at Visit 1. The blood sample volume will be 6 mL.

Sponsors & Collaborators

Principal Investigators

  • Ipsen Medical Director · Ipsen

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00710307 on ClinicalTrials.gov